Earnings Feed
Start Free
Home/Filings/4/0001354488-16-008420
4//SEC Filing

CorMedix Inc. 4

Accession 0001354488-16-008420

$CRMDCIK 0001410098operating
View on SEC.govCompany Profile

Filed

Oct 24, 8:00 PM ET

Accepted

Oct 25, 4:32 PM ET

Size

18.0 KB

Accession

0001354488-16-008420

Insider Transaction Report

Form 4
Period: 2016-10-21
CorMedix Inc.CRMD
Pfaffle Antony
Director
Transactions
  • Exercise/Conversion

    Common Stock, $0.001 par value per share

    2016-10-21$0.68/sh+20,000$13,600→ 20,000 total
  • Exercise/Conversion

    Stock Option (right to buy)

    2016-10-21−20,000→ 80,000 total
    Exercise: $0.68Exp: 2022-12-05→ Common Stock, $0.001 par value per share (20,000 underlying)
  • Sale

    Common Stock, $0.001 par value per share

    2016-10-21$2.23/sh−20,000$44,600→ 0 total
Holdings

  • Stock Option (right to buy)

    Exercise: $0.90Exp: 2023-03-22→ Common Stock, $0.001 par value per share (210,000 underlying)
    210,000

  • Stock Option (right to buy)

    Exercise: $3.13Exp: 2020-03-30→ Common Stock, $0.001 par value per share (20,000 underlying)
    20,000

  • Stock Option (right to buy)

    Exercise: $2.02Exp: 2024-01-09→ Common Stock, $0.001 par value per share (30,000 underlying)
    30,000

  • Stock Option (right to buy)

    Exercise: $5.00Exp: 2025-02-24→ Common Stock, $0.001 par value per share (75,000 underlying)
    75,000

  • Stock Option (right to buy)

    Exercise: $2.10Exp: 2021-01-14→ Common Stock, $0.001 par value per share (30,000 underlying)
    30,000

  • Stock Option (right to buy)

    Exercise: $2.02Exp: 2024-01-09→ Common Stock, $0.001 par value per share (100,000 underlying)
    100,000

  • Stock Option (right to buy)

    Exercise: $2.27Exp: 2024-04-01→ Common Stock, $0.001 par value per share (100,000 underlying)
    100,000
Footnotes (10)
  • [F1]This exercise and sale was effected pursuant to a Rule 10b5-1 trading plan executed by the reporting person on September 19, 2016.
  • [F10]These options were granted on February 24, 2015, and vested immediately.
  • [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.226 to $2.228, inclusive.
  • [F3]These options vested as follows: (a) fifty percent (50%) on the date of the issuance of the CE mark certification, which occurred on July 5th, 2013, and (b) fifty percent (50%) on December 31, 2013.
  • [F4]These options vested as follows: 1/3 on March 30, 2010; an additional 1/3 on March 30, 2011; and the remaining 1/3 on March 30, 2012.
  • [F5]These options vested on January 14, 2012.
  • [F6]These options vest based on performance milestones running through December 31, 2014.
  • [F7]The options vest in full on the first anniversary of the date of grant.
  • [F8]The options vested 100% on January 10, 2014.
  • [F9]The options vested 100% on April 2, 2014.

Documents

1 file

Issuer

CorMedix Inc.

CIK 0001410098

→
Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001410098

Filing Metadata

Form type
4
Filed
Oct 24, 8:00 PM ET
Accepted
Oct 25, 4:32 PM ET
Size
18.0 KB
View on SEC.gov